CN108472311B - 抗病毒剂和治疗病毒感染的方法 - Google Patents

抗病毒剂和治疗病毒感染的方法 Download PDF

Info

Publication number
CN108472311B
CN108472311B CN201780005078.4A CN201780005078A CN108472311B CN 108472311 B CN108472311 B CN 108472311B CN 201780005078 A CN201780005078 A CN 201780005078A CN 108472311 B CN108472311 B CN 108472311B
Authority
CN
China
Prior art keywords
copolymer
molecular weight
acrolein
daltons
polyalkylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780005078.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN108472311A (zh
Inventor
G.J.H.梅尔罗斯
M.K.迪利齐亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recce Ltd
Original Assignee
Recce Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016900595A external-priority patent/AU2016900595A0/en
Application filed by Recce Ltd filed Critical Recce Ltd
Publication of CN108472311A publication Critical patent/CN108472311A/zh
Application granted granted Critical
Publication of CN108472311B publication Critical patent/CN108472311B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • AIDS & HIV (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201780005078.4A 2016-02-19 2017-02-17 抗病毒剂和治疗病毒感染的方法 Active CN108472311B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2016900595 2016-02-19
AU2016900595A AU2016900595A0 (en) 2016-02-19 Method for treatment of cancer or viral infection
AU2016902715 2016-07-11
AU2016902715A AU2016902715A0 (en) 2016-07-11 Method for treatment of cancer or viral infection
PCT/AU2017/050139 WO2017139849A1 (en) 2016-02-19 2017-02-17 Anti-virus agent and method for treatment of viral infection

Publications (2)

Publication Number Publication Date
CN108472311A CN108472311A (zh) 2018-08-31
CN108472311B true CN108472311B (zh) 2021-06-22

Family

ID=59624666

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780005078.4A Active CN108472311B (zh) 2016-02-19 2017-02-17 抗病毒剂和治疗病毒感染的方法

Country Status (7)

Country Link
US (2) US11045491B2 (cg-RX-API-DMAC7.html)
EP (1) EP3416656B1 (cg-RX-API-DMAC7.html)
JP (1) JP6812436B2 (cg-RX-API-DMAC7.html)
CN (1) CN108472311B (cg-RX-API-DMAC7.html)
AU (2) AU2017220391B2 (cg-RX-API-DMAC7.html)
ES (1) ES2867453T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017139849A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3166468C (en) * 2020-01-31 2023-11-21 Graham John Hamilton Melrose Process for preparation of biologically active copolymer
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
AU2024405675A1 (en) * 2023-12-21 2026-07-16 Gramele Industrial Holdings Pty Ltd Methods of ameliorating microbial growth

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87108390A (zh) * 1986-12-23 1988-09-21 生物聚合物有限公司 抑制生物和杀生物的组合物
AU2010100972A4 (en) * 2009-10-19 2010-10-07 Chemeq Ltd Topical antimicrobial compositions
CN103936895A (zh) * 2007-11-07 2014-07-23 瑞克私人有限公司 抗微生物聚合物及其组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278126D1 (en) * 1981-09-30 1988-03-31 Nat Res Dev Sustained release compositions
PH23983A (en) 1986-12-23 1990-02-09 Biopolymers Ltd Biostatic and biocidal composition
AUPN327695A0 (en) 1995-05-30 1995-06-22 Chemeq Pty. Limited Chemotherapeutic compositions
ES2157025T3 (es) * 1996-02-22 2001-08-01 Degussa Copolimeros que liberan acroleina.
US6060571A (en) 1996-02-22 2000-05-09 Degussa Aktiengesellschaft Acrolein-releasing copolymers
US6060235A (en) 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US7629002B2 (en) 2000-02-16 2009-12-08 Chemeq Ltd. Antimicrobial polymeric compositions and method of treatment using them
NZ520639A (en) 2000-02-16 2004-06-25 Chemeq Ltd Antimicrobial polymeric compositions derived from acrolein
KR100971520B1 (ko) * 2002-01-18 2010-07-21 케멕 리미티드 위장 질환의 치료방법 및 이에 유용한 중합체 조성물
AUPS327102A0 (en) * 2002-06-28 2002-07-18 Chemeq Ltd Method of treatment or prophylaxis of gastrointestinal diseases
EA009674B1 (ru) * 2003-11-06 2008-02-28 Кемек Лтд. Способ получения полиакролеина
EP2186521A1 (en) 2008-11-14 2010-05-19 Mergemeier Steffen Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound
WO2011047420A1 (en) * 2009-10-19 2011-04-28 Chemeq Ltd Cosmetic compositions
WO2015160940A1 (en) * 2014-04-15 2015-10-22 President And Fellows Of Harvard College Bi-specific agents
AU2015349611B2 (en) * 2014-11-18 2018-07-26 Recce Pharmaceuticals Ltd Copolymer and method for treatment of bacterial infection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87108390A (zh) * 1986-12-23 1988-09-21 生物聚合物有限公司 抑制生物和杀生物的组合物
CN103936895A (zh) * 2007-11-07 2014-07-23 瑞克私人有限公司 抗微生物聚合物及其组合物
AU2010100972A4 (en) * 2009-10-19 2010-10-07 Chemeq Ltd Topical antimicrobial compositions

Also Published As

Publication number Publication date
CN108472311A (zh) 2018-08-31
EP3416656A1 (en) 2018-12-26
US11045491B2 (en) 2021-06-29
JP2019510731A (ja) 2019-04-18
AU2023201883A1 (en) 2023-05-04
US20180338994A1 (en) 2018-11-29
EP3416656B1 (en) 2021-04-21
JP6812436B2 (ja) 2021-01-13
AU2017220391B2 (en) 2023-01-19
HK1254547A1 (zh) 2019-07-19
US20210275573A1 (en) 2021-09-09
ES2867453T3 (es) 2021-10-20
AU2017220391A1 (en) 2018-05-17
WO2017139849A1 (en) 2017-08-24
EP3416656A4 (en) 2019-11-13
AU2023201883B2 (en) 2024-08-08

Similar Documents

Publication Publication Date Title
AU2023201883B2 (en) Anti-virus agent and method for treatment of viral infection
JP2010537997A (ja) 二機能性ポリマーに結合させたインフルエンザウイルス阻害剤
Yoshimoto et al. Development of Anti‐Influenza Drugs: II. Improvement of Oral and Intranasal Absorption and the Anti‐Influenza Activity of Stachyflin Derivatives
US12533329B2 (en) Compositions and methods of treatment with glutathione
JP6605602B2 (ja) 細菌感染の治療のためのコポリマーおよび方法
HK1254547B (en) Anti-virus agent and method for treatment of viral infection
US20220401469A1 (en) Process for preparation of biologically active copolymer
US20240150441A1 (en) Monoclonal antibodies against sars-cov-2 and variants
US20240390413A1 (en) Polymers obtained by the reaction of a phenolic compound and a carbonyl compound as anti-sars-cov-2 agents
HK40103746A (en) Copolymer and method for treatment of bacterial infection
WO2025174376A1 (en) Compositions and methods for bimodal anti-viral combination therapy
WO2007040426A1 (en) Antiviral agent
CN113398120A (zh) 阿比多尔在制备预防或治疗SARS-CoV-2病毒所致疾病的药物中的用途
JP2005526121A (ja) 抗ライノウイルス活性物質

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1254547

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant